TIS tissue therapies limited

rbs morgans bullish in latest update

  1. 3,627 Posts.
    lightbulb Created with Sketch. 336
    They attach some degree of import to the EU clinical trials in a balanced update. Suggest good figures from this will provide short term catalyst, and have rerated to BUY with target price adjusted from 0.70 to 0.94.

    Will be interesting to see what credibility punters give this in the current climate...

    Rgds,

    Lilac
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.